Back to Search
Start Over
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
- Source :
- Clinical and Translational Oncology. 24:2251-2253
- Publication Year :
- 2022
- Publisher :
- Springer Science and Business Media LLC, 2022.
- Subjects :
- Cancer Research
Oncology
General Medicine
Subjects
Details
- ISSN :
- 16993055
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- Clinical and Translational Oncology
- Accession number :
- edsair.doi...........70ea6814c47840cb8641d12206d0b2cc
- Full Text :
- https://doi.org/10.1007/s12094-022-02928-2